Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1378780.RAsQPuwG67xHU0mf5JMu47XMXheVMRNA3Hs_ftN2XpnEg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1378780.RAsQPuwG67xHU0mf5JMu47XMXheVMRNA3Hs_ftN2XpnEg130_assertion type Assertion NP1378780.RAsQPuwG67xHU0mf5JMu47XMXheVMRNA3Hs_ftN2XpnEg130_head.
- NP1378780.RAsQPuwG67xHU0mf5JMu47XMXheVMRNA3Hs_ftN2XpnEg130_assertion description "[Mice immunized with murine mammary carcinoma cells genetically engineered to secrete interleukin-2 (IL-2) are rendered resistant to subsequent challenge with unmodified tumor cells, and in the case of mice bearing established tumors, the rate of development of pulmonary metastases is reduced.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1378780.RAsQPuwG67xHU0mf5JMu47XMXheVMRNA3Hs_ftN2XpnEg130_provenance.
- NP1378780.RAsQPuwG67xHU0mf5JMu47XMXheVMRNA3Hs_ftN2XpnEg130_assertion evidence source_evidence_literature NP1378780.RAsQPuwG67xHU0mf5JMu47XMXheVMRNA3Hs_ftN2XpnEg130_provenance.
- NP1378780.RAsQPuwG67xHU0mf5JMu47XMXheVMRNA3Hs_ftN2XpnEg130_assertion SIO_000772 9259972 NP1378780.RAsQPuwG67xHU0mf5JMu47XMXheVMRNA3Hs_ftN2XpnEg130_provenance.
- NP1378780.RAsQPuwG67xHU0mf5JMu47XMXheVMRNA3Hs_ftN2XpnEg130_assertion wasDerivedFrom befree-2016 NP1378780.RAsQPuwG67xHU0mf5JMu47XMXheVMRNA3Hs_ftN2XpnEg130_provenance.
- NP1378780.RAsQPuwG67xHU0mf5JMu47XMXheVMRNA3Hs_ftN2XpnEg130_assertion wasGeneratedBy ECO_0000203 NP1378780.RAsQPuwG67xHU0mf5JMu47XMXheVMRNA3Hs_ftN2XpnEg130_provenance.